Literature DB >> 6157009

The cerebrospinal fluid and plasma concentrations of gamma-trace and beta2-microglobulin at various ages and in neurological disorders.

H Löfberg, A O Grubb, T Sveger, J E Olsson.   

Abstract

The concentrations of gamma-trace and beta2-microglobulin in cerebrospinal fluid (CSF) and plasma were determined in 64 individuals of various ages without signs of organic disorder in the central nervous system (CNS). A strong connection was found between the CSF level of gamma-trace and the age of the individual, with the CSF level of newborns being 3--4 times that of adults. A similar, but less marked, connection was found for the CSF level of beta2-microglobulin and the age of the individual. The plasma levels of the two proteins also varied with the age of the individual, but the variations were not as great as those of the CSF levels. The results strongly emphasize the necessity of using age-matched reference values when CSF and plasma levels of the proteins are to be evaluated in different groups of patients. Thirteen children and 98 adults with various neurological disorders were also examined. Significantly increased CSF levels of gamma-trace and beta2-microglobulin as well as increased plasma concentration of gamma-trace and CSF/plasma gradient of beta2-microglobulin were found in infectious disorders. Increased gamma-trace concentration in plasma and beta2-microglobulin concentration in CSF were seen in cerebrovascular disorders. The mechanisms which regulate the turnover of proteins in CSF are discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6157009     DOI: 10.1007/BF00313180

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  35 in total

1.  PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.

Authors:  G A SCHUMACHER; G BEEBE; R F KIBLER; L T KURLAND; J F KURTZKE; F MCDOWELL; B NAGLER; W A SIBLEY; W W TOURTELLOTTE; T L WILLMON
Journal:  Ann N Y Acad Sci       Date:  1965-03-31       Impact factor: 5.691

2.  Proteins in normal cerebrospinal fluid not found in serum.

Authors:  J CLAUSEN
Journal:  Proc Soc Exp Biol Med       Date:  1961-05

3.  Low molecular weight proteinuria.

Authors:  Y Manuel; A Colle; M Leclercq; C Tonnelle
Journal:  Contrib Nephrol       Date:  1975       Impact factor: 1.580

4.  Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values.

Authors:  G Tibbling; H Link; S Ohman
Journal:  Scand J Clin Lab Invest       Date:  1977-09       Impact factor: 1.713

5.  Protein size and cerebrospinal fluid composition.

Authors:  K Felgenhauer
Journal:  Klin Wochenschr       Date:  1974-12-15

6.  Serum 2 -microglobulin in renal disease.

Authors:  L Wibell; P E Evrin; I Berggård
Journal:  Nephron       Date:  1973       Impact factor: 2.847

7.  Isolation and properties of a low molecular weight beta-2-globulin occurring in human biological fluids.

Authors:  I Berggård; A G Bearn
Journal:  J Biol Chem       Date:  1968-08-10       Impact factor: 5.157

8.  Serum-CSF protein gradients, the blood-GSF barrier and the local immune response.

Authors:  G Schliep; K Felgenhauer
Journal:  J Neurol       Date:  1978-05-18       Impact factor: 4.849

9.  Pathogenesis of brain edema and hemorrhage: role of the brain capillary.

Authors:  G W Goldstein
Journal:  Pediatrics       Date:  1979-09       Impact factor: 7.124

10.  Gamma globulins of CSF and serum in multiple sclerosis: isoelectric focusing on polyacrylamide gel and agar gel electrophoresis.

Authors:  J E Olsson; K Nilsson
Journal:  Neurology       Date:  1979-10       Impact factor: 9.910

View more
  7 in total

1.  Elevation of cystatin C in susceptible neurons in Alzheimer's disease.

Authors:  A Deng; M C Irizarry; R M Nitsch; J H Growdon; G W Rebeck
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

2.  Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Icelandic type is a variant of gamma-trace basic protein (cystatin C).

Authors:  J Ghiso; O Jensson; B Frangione
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

Review 3.  Unifying features of systemic and cerebral amyloidosis.

Authors:  J Ghiso; T Wisniewski; B Frangione
Journal:  Mol Neurobiol       Date:  1994-02       Impact factor: 5.590

4.  Elevated cerebrospinal fluid levels of beta-2-microglobulin in patients with Guillain-Barré syndrome and their correlations with clinical features.

Authors:  Ming-Qi Liu; Jing Wang; Chen-Na Huang; Yuan Qi; Lin-Jie Zhang; Ming Yi; Sheng-Hui Chang; Li-Sha Sun; Li Yang
Journal:  Neurol Sci       Date:  2021-02-17       Impact factor: 3.307

Review 5.  Cystatin C--properties and use as diagnostic marker.

Authors:  A O Grubb
Journal:  Adv Clin Chem       Date:  2000       Impact factor: 5.394

6.  Amyloid fibril in hereditary cerebral hemorrhage with amyloidosis (HCHWA) is related to the gastroentero-pancreatic neuroendocrine protein, gamma trace.

Authors:  D H Cohen; H Feiner; O Jensson; B Frangione
Journal:  J Exp Med       Date:  1983-08-01       Impact factor: 14.307

7.  Evaluation of putative CSF biomarkers in paediatric spinal muscular atrophy (SMA) patients before and during treatment with nusinersen.

Authors:  Jessika Johannsen; Deike Weiss; Anne Daubmann; Leonie Schmitz; Jonas Denecke
Journal:  J Cell Mol Med       Date:  2021-07-27       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.